The following antibodies were purchased from BD: CD45.1 BV711 (A20), CD117 BUV395 (2B8), CD135 APC & PE-CF594 (A2F10.1), MHC II V500, BV421, BV510 (M5/114.15.2), CD24 BUV496 (M1/69), CD127 BV421 (SB/199), CD45RA PE (14.8), CD19 BV42 1(1D3). From eBioscience: CD117 PE-Cy7 (2B8), CD317 eFluor450 & APC (eBio927), CD115 PE (AFS98), APC eFluor780 anti-CD11c (N418), MHC II eFluor450 (M5/114/15/2), CD24 PE-Cy7 (M1/69), CD172a APC & PerCP-eFluor710 (P84), Siglec-H PerCP-eFluor710 (eBio440C), eFluor450 Ter119 (Ter119), CD105 eFluor450 (MJ7/18), Irf8 PerCP-eFluor710 (V3GYWCH), CD45R eFluor450 (RA3-6B2), NK1.1 eFluor450 (PK136), CD3 eFluor450 (17A2), Irf4 PE (3E4). From Tonbo Biosciences: CD45.1 PE-Cy7 (A20), CD115 PE (AFS98), CD11c APC-Cy7 (N418). From BioLegend: CD115 BV711 (ASF98), CD45.1 Alexa Fluor 488 (A20), Flag (DYKDDDDK) APC (L5).
Lineage cell depletion kit was purchased from Miltenyi. Cells were analyzed on FACSCanto II or FACSAria Fusion flow cytometers (BD), and data analyzed with FlowJo software (Tree Star).